Status:

UNKNOWN

ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation

Lead Sponsor:

Medical University of Vienna

Conditions:

Renal Transplant Rejection

Immune Repertoire

Eligibility:

All Genders

Brief Summary

In this study, the investigators will establish a workflow to generate unique patterns of the donor-reactive T cell repertoire using mixed lymphocyte reactions to select alloreactive T cell clones pri...

Detailed Description

Kidney transplant recipients receiving a non lymphodepletional induction therapy at the investigators center will be included in this study. Alloreactive T cells are defined prior to transplantation ...

Eligibility Criteria

Inclusion

  • Kidney transplantation in our center

Exclusion

  • Donor not evaluated by our center

Key Trial Info

Start Date :

July 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2024

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03422224

Start Date

July 1 2017

End Date

July 1 2024

Last Update

October 23 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical university of Vienna

Vienna, Austria, 1090